Research Library

Narendra Modi was sworn in as India’s new prime minister on Monday, a little over a week after a landslide victory at the polls. The resounding win gives Modi much greater freedom to implement his agenda than any Indian leader in recent years, says international economics fellow Russell Green. What will Modi’s India look like, and how will it affect the U.S.? Green, who spent four years in India as the U.S. Treasury Department’s first financial attaché to that country, explains.

Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.

By Rehman Bhalesha

Jury nullification — when a jury disagrees with the law and acquits a defendant they believe to be…

The technical problems plaguing the health exchange roll-out came without warning, and health policy scholar Elena Marks, an advocate of health care reform, is not happy about it. Read her Oct. 25, 2013, blog.